Hyperthermic Intraperitoneal Chemotherapy plus Intravenous Chemotherapy of Paclitaxel with or without Sintilimab in Gastric Cancer: A Comparative Study

Table 1

Comparison of the general data.

	Control (n = 60)		Study (n = 60)
	No.	%	No.	%
Age, years
≤60	26	43.33	19	31.67
>60	34	56.67	41	68.33
Gender
Male	35	58.33	39	65.00
Female	25	41.67	21	35.00
Pathological type
Adenocarcinoma	55	91.67	57	95.00
Others	5	8.33	3	5.00
ECOG score
0	42	70.00	39	65.00
1	18	30.00	21	35.00
Differentiations
Low	11	18.33	14	23.33
Medium/High	49	81.67	46	76.67

ECOG, Eastern Cooperative Oncology Group.